COP vs SGMO · P/E 19, rev $58.94B vs rev $57.8M
ConocoPhillips (COP) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the COP and SGMO stock pages for the full models.
Not investment advice.